News
Ranitidine: all products are out of stock as investigations continue
BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l6746 (Published 28 November 2019) Cite this as: BMJ 2019;367:l6746
- Elisabeth Mahase
- The BMJ
All ranitidine products (injectable and oral) are “expected to be out of stock with no date for resupply until further notice,” the Department of Health and Social Care has told doctors.1
In an updated statement, the department added injectable products to the list of ranitidine products that should no longer be prescribed. …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.